[go: up one dir, main page]

ES2123922T3 - Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida. - Google Patents

Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.

Info

Publication number
ES2123922T3
ES2123922T3 ES95400750T ES95400750T ES2123922T3 ES 2123922 T3 ES2123922 T3 ES 2123922T3 ES 95400750 T ES95400750 T ES 95400750T ES 95400750 T ES95400750 T ES 95400750T ES 2123922 T3 ES2123922 T3 ES 2123922T3
Authority
ES
Spain
Prior art keywords
antagonist
substance
composition
cosmetic composition
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95400750T
Other languages
English (en)
Inventor
Lacharriere Olivier De
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9462919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123922(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2123922T3 publication Critical patent/ES2123922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE UN ANTAGONISTA DE SUSTANCIA P EN UNA COMPOSICION COSMETICA, PARA TRATAR LAS PIELES SENSIBLES. SE REFIERE EN PARTICULAR A LA UTILIZACION DE UN ANTAGONISTA DE SUSTANCIA P PARA PREVENIR Y/O LUCHAR CONTRA LAS IRRITACIONES CUTANEAS Y/O LOS HERPES Y/O LOS ERITEMAS Y/O LAS SENSACIONES INESTETICAS Y/O LAS SENSACIONES DE CALENTAMIENTO Y/O LOS PRURITOS DE LA PIEL.
ES95400750T 1994-05-05 1995-04-04 Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida. Expired - Lifetime ES2123922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405537A FR2719474B1 (fr) 1994-05-05 1994-05-05 Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Publications (1)

Publication Number Publication Date
ES2123922T3 true ES2123922T3 (es) 1999-01-16

Family

ID=9462919

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95400750T Expired - Lifetime ES2123922T3 (es) 1994-05-05 1995-04-04 Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.

Country Status (9)

Country Link
US (2) US6235291B1 (es)
EP (1) EP0680749B1 (es)
JP (1) JP2783520B2 (es)
AT (1) ATE170741T1 (es)
BR (1) BR9501652A (es)
CA (1) CA2148652C (es)
DE (1) DE69504567T2 (es)
ES (1) ES2123922T3 (es)
FR (1) FR2719474B1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728165A1 (fr) † 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
US5672640A (en) * 1995-07-12 1997-09-30 Caschem, Inc. Polypropylene compatible grease compositions for optical fiber cable
BR9610375A (pt) * 1995-09-07 1999-07-06 Oreal Extrato de células composição cosmética ou farmacêutica utilização de pelo menos um extrato de células e processo de tratamento cosmético
FR2746642B1 (fr) * 1996-03-27 1998-05-15 Oreal Composition apaisante comprenant un extrait bacterien
FR2746647B1 (fr) * 1996-03-27 1998-05-15 Oreal Composition apaisante comprenant un extrait d'iridacee
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2740040B1 (fr) * 1995-10-23 1997-12-05 Oreal Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
FR2740332B1 (fr) * 1995-10-26 1997-12-05 Oreal Composition pour la deformation permanente des fibres keratiniques, contenant un antagoniste de substance p ou un antagoniste de cgrp
FR2741262B1 (fr) * 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
FR2741802B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine pour traiter les peaux sensibles
FR2743813B1 (fr) 1996-01-23 1998-02-20 Oreal Composition gelifiee stable a forte teneur en electrolyte
FR2746007B1 (fr) 1996-03-12 1998-04-24 Composition gelifiee stable a forte teneur en electrolyte et son utilisation dans les domaines cosmetique, pharmaceutique et/ou dermatologique
JPH09255547A (ja) * 1996-03-22 1997-09-30 Kao Corp 皮膚外用剤
US6776980B1 (en) 1996-07-01 2004-08-17 L'oreal Photoprotective/cosmetic compositions comprising dibenzoylmethane/triazine/diphenylacrylate compounds
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
US8466109B2 (en) * 1998-10-05 2013-06-18 Laboratoires Expanscience Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology
JP4447685B2 (ja) * 1999-01-14 2010-04-07 第一三共株式会社 皮膚乾燥症治療剤
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
US20030225326A1 (en) * 2002-04-03 2003-12-04 Bernard Querleux Methods and combinations relating to information obtained using brain imaging techniques
DE10223221A1 (de) * 2002-05-24 2003-12-11 Sebapharma Gmbh & Co Kg Kosmetische Zusammensetzung mit hautentquellender Wirkung
EP1374913A1 (fr) * 2002-06-25 2004-01-02 L'oreal Procédés non thérapeutiques d'évaluation de la neuro-sensibilité cutanée, kit et utilisation d'un kit
US8100830B2 (en) 2002-06-25 2012-01-24 Societe L'oreal S.A. Non-therapeutic methods of evaluating skin neurosensitivity, kit and use of a kit for implementing the method
FR2841136B1 (fr) * 2002-06-25 2004-08-13 Oreal Procede non therapeutiques d'evaluation de la neuro-sensibilite cutanee, kit et utilisation du kit pour mettre en oeuvre le procede
DE102004020646A1 (de) * 2004-04-22 2005-11-24 Coty B.V. Schweißabsorbierender Komplex für kosmetische Produkte
DE102004020647A1 (de) * 2004-04-22 2005-11-24 Coty B.V. Schweißabsorbierender Komplex für kosmetische Produkte
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
US20070154448A1 (en) * 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing
TWI415628B (zh) * 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
MY177591A (en) 2006-10-16 2020-09-22 Lion Corp Nk1 receptor antagonist composition
FR2918883B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE297062C (es)
US3266934A (en) 1962-12-04 1966-08-16 John R Alexander Removal of contaminants from interiors of enclosures
LU65373A1 (es) 1972-05-17 1973-11-23
US3772431A (en) 1972-09-21 1973-11-13 W Mlkvy Effervescent mouthwash tablet
US3888976A (en) 1972-09-21 1975-06-10 William P Mlkvy Zinc and strontium ion containing effervescent mouthwash tablet
WO1983001252A1 (en) * 1981-10-09 1983-04-14 Hakanson, Rolf A drug based on a substance p antagonist
JP2519024B2 (ja) 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
DE3338957A1 (de) 1983-10-27 1985-05-15 Keyhan Dipl.-Ing. 6908 Wiesloch Ghawami Enthaarungsmittel
US4837026A (en) 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
US4986981A (en) 1986-07-07 1991-01-22 Den Mat Corporation Toothpaste having low abrasion
DE3627746A1 (de) 1986-08-16 1988-02-18 Henkel Kgaa Verfahren zur dauerhaften haarverformung
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
SE8701372L (sv) 1987-04-02 1988-10-03 Boliden Ab Foerfarande och medel foer konservering av hoe
IE64995B1 (en) * 1987-07-14 1995-09-20 Warner Lambert Co Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
CA2014201A1 (en) 1989-04-26 1990-10-26 Albemarle Corporation Solid non-hygroscopic trialkylamine oxides
US5202130A (en) 1989-08-31 1993-04-13 The Johns Hopkins University Suppression of eczematous dermatitis by calcium transport inhibition
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
ATE94399T1 (de) 1990-01-29 1993-10-15 Wogepharm Gmbh Verfahren zur herstellung von mitteln zur therapie von hauterkrankungen.
DE69105131T2 (de) * 1990-06-01 1995-03-23 Pfizer 3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
JPH0446114A (ja) 1990-06-13 1992-02-17 Kao Corp 毛髪処理剤組成物
FR2677361A1 (fr) * 1991-06-04 1992-12-11 Adir Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5288730A (en) * 1991-06-24 1994-02-22 Merck Sharp & Dohme Limited Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
EP0593557B1 (en) 1991-07-05 1996-01-31 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
CA2110514A1 (en) 1991-07-05 1993-01-21 Raymond Baker Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
ATE133658T1 (de) 1991-07-10 1996-02-15 Merck Sharp & Dohme Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung
US5495047A (en) * 1991-07-10 1996-02-27 Merck, Sharp & Dohme (Ltd.) Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
EP0600952B1 (en) 1991-08-20 1996-04-17 MERCK SHARP & DOHME LTD. Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
GB9201179D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
JPH05339240A (ja) * 1992-06-04 1993-12-21 Yamanouchi Pharmaceut Co Ltd テトラヒドロイソキノリンアミド誘導体
DE9211006U1 (de) 1992-08-17 1993-12-16 Kao Corporation GmbH, 40472 Düsseldorf Mittel zur Haarbehandlung
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
CA2114968A1 (en) 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5492927A (en) 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
FR2728258A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un derive de l'ethylene diamine dans une composition cosmetique ou dermatologique et composition contenant notamment un produit a effet secondaire irritant
FR2728265A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
US5716625A (en) 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
AU4690196A (en) 1994-12-21 1996-07-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5756107A (en) 1994-12-21 1998-05-26 Cosmederm Technologies Formulations and methods for reducing skin irritation
JPH11502504A (ja) 1994-12-21 1999-03-02 コスメダーム・テクノロジーズ 皮膚刺激を軽減するための製剤および方法
WO1996019182A1 (en) 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2740332B1 (fr) 1995-10-26 1997-12-05 Oreal Composition pour la deformation permanente des fibres keratiniques, contenant un antagoniste de substance p ou un antagoniste de cgrp

Also Published As

Publication number Publication date
EP0680749B1 (fr) 1998-09-09
BR9501652A (pt) 1996-03-05
CA2148652A1 (fr) 1995-11-06
JPH07304649A (ja) 1995-11-21
DE69504567D1 (de) 1998-10-15
DE69504567T2 (de) 1999-02-04
US6235291B1 (en) 2001-05-22
US20010014342A1 (en) 2001-08-16
EP0680749A2 (fr) 1995-11-08
CA2148652C (fr) 2002-12-17
FR2719474B1 (fr) 1996-05-31
JP2783520B2 (ja) 1998-08-06
EP0680749A3 (fr) 1996-09-11
ATE170741T1 (de) 1998-09-15
FR2719474A1 (fr) 1995-11-10

Similar Documents

Publication Publication Date Title
ES2123922T3 (es) Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.
ES2154388T3 (es) Utilizacion de un antagonista de cgrp en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida.
ES2118009T3 (es) Utilizacion de un antagonista de bradiquinina en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida.
ES2181812T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
ES2130868T3 (es) Utilizacion de un extracto de al menos una iridacea en el tratamiento de las arrugas.
ES2185241T3 (es) Utilizacion de composiciones cosmeticas que contienen al menos una uxina.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
ES2176700T3 (es) Composiciones para la piel.
ES2060983T3 (es) Utilizacion en cosmetica de una dispersion acuosa a base de organopolisilosanos y un copolimero de acrilato de amonio/acrilamida reticulados.
ES2045479T3 (es) Metodo cosmetico que utiliza un extracto de las partes aereas de cichorium intybus l.
ES2111412T3 (es) Aplicador de espuma para el cuidado y el tratamiento topico de la piel.
ES2113223T3 (es) Utilizacion de un antagonista de substancia p en una composicion topica como agente antitranspirante.
ES2175295T3 (es) Uso de un poliholosido en una composicion destinada a favorecer la descamcion de la piel y su composicion.
AU3003199A (en) Tourmaline in cosmetic cleansing compositions
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
ES2161888T3 (es) Utilizacion de la laminarina y de los oligosacaridos derivados de laminarina en cosmetologia y para la fabricacion de un medicamento destinado al tratamiento de la piel.
ES2183341T3 (es) Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados.
ES2125734T3 (es) Utilizacion de un 2-amino-alcano-1,3-diol para frenar la caida de los cabellos y/o inducir y estimular su crecimiento.
ES2161088T3 (es) Utilizacion de un extracto de sanguisorba officinalis para favorecer la pigmentacion de la piel y/o de los cabellos.
ES2161020T3 (es) Composicion cosmetica o dermatologica que comprenden un polimero filmogeno, procedimiento de maquillaje y de tratamiento no terapeutico.
DK1014934T3 (da) Anvendelse af mindst en ekstrakt af slægten Chrysanthenum til fremme af pigmenteringen af huden og/eller håret
ES2094070T3 (es) Composicion cosmetica y/o dermatologica gelificada, rica en disolvente y conteniendo particulas huecas.
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 680749

Country of ref document: ES